Time Restricted Eating for Sleep Deprivation
(CRISP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Short sleep duration confers high cardiovascular and metabolic risk, but lifestyle factors and molecular mechanisms that contribute to increased blood pressure and poor glucose control during short sleep are not completely understood. Habitual short sleepers are constantly eating, the proposed studies will evaluate if this behavior contributes to heightened cardiovascular and metabolic risk. The study will evaluate if restricted eating duration (8 hours/day) could improve cardiovascular and metabolic health in habitual short sleepers.
Will I have to stop taking my current medications?
The trial allows the use of certain medications like birth control, second-generation antihistamines, antacids, and acne-related ointments. However, if you are taking medications for chronic conditions like high blood pressure, high cholesterol, or diabetes, you may not be eligible to participate. It's best to discuss your specific medications with the study team.
Is time-restricted eating safe for humans?
Time-restricted eating (TRE) has been studied in humans and is generally considered safe, with research showing it can lead to weight loss and metabolic benefits without altering diet quality. However, individual responses can vary, and it's important to consult with a healthcare provider before starting any new dietary regimen.12345
How is time-restricted eating different from other treatments for sleep deprivation?
Time-restricted eating (TRE) is unique because it focuses on limiting the hours during which you eat each day, rather than what you eat. This approach is different from other treatments for sleep deprivation, which might focus on sleep hygiene or medication, as it potentially influences sleep patterns by regulating eating times.12367
What data supports the effectiveness of the treatment Time Restricted Eating (TRE) for sleep deprivation?
Who Is on the Research Team?
Prachi Singh, PhD
Principal Investigator
Pennington Biomedical Research Institute
Are You a Good Fit for This Trial?
This trial is for adults aged 18-45 with a BMI of 25-35 who usually sleep less than 6.5 hours and eat over a span of more than 14 hours per day. They should not have chronic health issues like hypertension or diabetes, but those with prehypertension or prediabetes may join if they agree to use birth control (if applicable) and can follow the study's eating schedule.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either time restricted eating (8h/day) or habitual eating duration (>14h/day) for 4 weeks
Follow-up
Participants are monitored for changes in cardiovascular and metabolic markers after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Time restricted eating (TRE)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pennington Biomedical Research Center
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator